A news blog for the MUSC Department of Surgery

The CCT developed an antibody test in less than a month using plasmid from Mount Sinai Laboratory.

Researchers at MUSC, including Hongjun Wang, Ph.D. hope to offer patients a new therapy to T1D.

Research Roadmap Supports Innovation as Driver to Improving Patient Outcomes